Chinese Journal of Pharmacovigilance ›› 2021, Vol. 18 ›› Issue (8): 766-768.
DOI: 10.19803/j.1672-8629.2021.08.14

Previous Articles     Next Articles

Current Adverse Drug Reaction Reporting and Monitoring of Essential Medicines in China

YU Hongli1, PANG Yu1, SHAO Bo1, XIAO Aili1, YU Dongmei*   

  1. 1Center for Drug Reevaluation, NMPA, Beijing 100022, China;
    *Center for Food Evaluation, State Administration for Market Regulation, Beijing 100070, China
  • Received:2020-02-03 Online:2021-08-15 Published:2021-08-17

PDF (PC)

713

Abstract: Objective To analyze the levels of reporting and monitoring of adverse drug reactions of essential medicines in recent years in China so as to provide reference for clinical safe use. Methods The Annual Reports on National ADR Monitoring issued by the National Medical Products Administration between 2015 and 2019 were collected while those on ADR/ADE involving national essential medicines were summarized and analyzed. Results From 2015 to 2019, reports of ADR/ADE caused by essential medicines in China kept increasing, which was consistent with the overall trend of reports in China. Conclusion With the improvement of regulations on essential medicines in China, ADR related to essential medicines deserve attention in order to promote the safe clinical use.

Key words: essential medicines, annual reports on national ADR monitoring, ADR/ADE

CLC Number: